SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated…
JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) -- RESPILEAN In a world where we measure everything—from step counts to calories—there’s…
March 31, 2025 17:00 ET | Source: Zealand Pharma Company announcement – No. 8 / 2025 Total number of shares…
Company presented clinical and preclinical data at the MDA Conference last week in Dallas, TexasOral presentation included data from MuSK-MG…
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à…
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based…
SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed…
February 28, 2025 02:42 ET | Source: Nxera Pharma Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin…
February 27, 2025 19:05 ET | Source: Nxera Pharma Cenerimod is a novel oral S1P1 receptor modulator with potential to…
February 07, 2025 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE)…
